Covidien plc

Covidien — Merger or Acquisition (August 2014)

25 slides from Covidien's merger presentation, Aug 8, 2014

  1. Slide 1: Town Hall Meeting

    Town Hall Meeting August 8, 2014 Omar Ishrak Chairman and CEO Medtronic, Inc. Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form

  2. Slide 2: Medtronic to Acquire Covidien

    Medtronic to Acquire Covidien Creates the premier global medical technology and services company with unmatched breadth and patient reach

  3. Slide 3: The Medtronic Mission: A Shared Sense of Purpose

    The Medtronic Mission: A Shared Sense of Purpose To contribute to human welfare…alleviate pain, restore health, and extend life… To direct our growth in the areas of maximum strength and ability…to continuously build on these areas through education and knowledge… To strive without reserve for the g

  4. Slide 4: Universal Healthcare Needs

    Improve Clinical Outcomes Expand Access Optimize Cost and Efficiency Universal Healthcare Needs

  5. Slide 5: Strategies to Address Healthcare Needs

    Economic Value Globalization Strategies Therapy Innovation Universal HC needs Improve clinical outcomes Expand access Optimize cost and efficiency Strategies to Address Healthcare Needs

  6. Slide 6: Joe Almeida, Chairman, President & CEO, Covidien

    Joe Almeida Chairman, President & CEO, Covidien • President and CEO since 2011 • Chairman since 2012 • 17 years with Covidien • 23 years industry experience • Chairman, AdvaMed Board of Directors • Partners in Health, Business Roundtable • Board Member, State Street Bank • B.S. in Mechanical Enginee

  7. Slide 7: Medtronic | Covidien

    &} Medtronic | E ai covipien

  8. Slide 8: Strategic Fit

    Strategic Fit

  9. Slide 9: Combination Results in Strategic Diversification

    Combination Results in Strategic Diversification Surgical Solutions Respiratory & Patient Care Surgical Solutions Respiratory & Patient Care

  10. Slide 10: A Strong Strategic Fit

    Delivering strong launch cadence of meaningful therapies and procedures Addressing the inequities in healthcare access globally Becoming a leader in value-based healthcare by incorporating EV into our DNA Uniquely positioned to expand our industry- leading franchises through our three differentiated

  11. Slide 11: Three Key Benefits for Medtronic and Covidien

    Three Key Benefits for Medtronic and Covidien Therapy Innovation Therapy Innovation 1. Strengthen and enhance Peripheral Vascular and Neuroscience portfolios 2. Leverage adjacencies in Medtronic Surgical Technologies and Covidien Surgical Solutions 3. Accelerate market adoption of early stage Covidi

  12. Slide 12: Combined Company Immediately Accelerates Ability to Expand Global Access

    Combined Company Immediately Accelerates Ability to Expand Global Access countries 150 + locations 300 + combined EM revenue $3.7B Broader presence facilitates more rapid expansion Covidien products such as surgical tools and capital equipment are adopted earlier in hospitals, becoming a base for Me

  13. Slide 13: Opportunities to Become Robust Integrated Health Solutions Partner

    Cath Lab Managed Services (Europe) Cardiac & Vascular Line Administrator (U.S.) General Surgery Line Administrator (U.S.) General Surgery Managed Services (Europe) Opportunities to Become Robust Unmatched Integrated Health Solutions Partner Economic Value Cardiocom Covidien Sensors Value primarily r

  14. Slide 14: Integration Guidelines

    Integration Guidelines

  15. Slide 15: Guiding Principles for Integration

    Guiding Principles for Integration • Continue to act as independent companies until transaction close • Keep focus and protect current business momentum in our respective companies • Plan for integration now to be ready for Day 1 post-close • Focus on creating lasting value beyond stated cost synerg

  16. Slide 16: Integration Team Structure

    Integration Team Structure Medtronic Medtronic Geoff Martha Bill Burke Medtronic Steering Committee Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Cross-functional teams Commercial teams Functional teams Med

  17. Slide 17: Combined Impact

    Combined Impact

  18. Slide 18: Accelerating Covidien Early Stage Therapies

    Accelerating Covidien Early Stage Therapies Interventional Lung: For Lung Cancer Interventional GI (Barrett's): For Barrett's Esophagus (pre-cancerous) Stroke: SWIFT PRIME Clinical Trial Open to Minimally Invasive Surgery: e.g. Bariatric Minimally Invasive Surgery Capnography: CO 2 Monitoring

  19. Slide 19: Transforming Healthcare Around the World to Improve More Lives Together

    Transforming Healthcare Around the World to Improve More Lives Together: Every seconds $27 Billion Healthcare Leader 87,000+ Employees Life-Changing Impact for Millions of Patients

  20. Slide 20: Q&A

    Q&A ?

  21. Slide 21: Disclaimers

    Disclaimers NO OFFER OR SOLICITATION This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pur

  22. Slide 22: Disclaimers (cont'd)

    Disclaimers (cont’d) PARTICIPANTS IN THE SOLICITATION Medtronic, New Medtronic and Covidien and certain of their respective directors and executive officers and employees may be considered participants in the solicitation of proxies from the respective shareholders of Medtronic and Covidien in respe

  23. Slide 23: Disclaimers (cont'd)

    Disclaimers (cont’d) Cautionary Statement Regarding Forward-Looking Statements Statements contained in this communication that refer to New Medtronic’s, Medtronic's and/or Covidien’s estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-loo

  24. Slide 24: Disclaimers (cont'd)

    Disclaimers (cont’d) Statement Required by the Irish Takeover Rules The directors of Medtronic accept responsibility for the information contained in this document. To the best of the knowledge and belief of the directors of Medtronic (who have taken all reasonable care to ensure that such is the ca

  25. Slide 25: Town Hall Meeting

    Town Hall Meeting Omar Ishrak Chairman and CEO Medtronic, Inc.

Covidien — Merger or Acquisition (August 2014) on 6ix